Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation

Experimental and Molecular Medicine

Volumn 38, Issue 3, 2006, Pages 284-294

  Kim, Eun Young ^a   Lee, Eun Na ^a   Lee, Jienny ^a   Park, Hae Jung ^a   Chang, Chi Young ^a   Jung, Da Yeon ^a   Choi, Su Young ^a   Lee, Suk Koo ^a   Joh, Jae Won ^a   Kim, Sung Joo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Antigens, CD45; CD4 positive T lymphocytes; CD40 ligand; Skin transplantation; Transplantation, homologous

Indexed keywords

ABATACEPT; CD40 LIGAND MONOCLONAL ANTIBODY; CD45 ANTIGEN; HB 220; INTERLEUKIN 10; INTERLEUKIN 4; MONOCLONAL ANTIBODY; MR 1;

ACUTE GRAFT REJECTION; ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG INHIBITION; EFFECTOR CELL; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SKIN TRANSPLANTATION; SPLEEN CELL; T CELL DEPLETION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

MURINAE;

EID: 33745859694     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2006.34     Document Type: Article

References (29)

1. Auersvald LA, Rothstein DM, Oliveira SC, Khuong CQ, Onodera H, Lazarovits AI, Basadonna GP. Indefinite islet allograft survival in mice after a short course of treatment with anti-CD45 monoclonal antibodies. Transplantation 1997;63:1355-8
2. Basadonna GP, Auersvald L, Khuong CQ, Zheng XX, Kashio N, Zekzer D, Minozzo M, Qian H, Visser L, Diepstra A, Lazarovits AI, Poppema S, Strom TB, Rothstein DM. Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy. Proc Natl Acad Sci USA 1998;95:3821-6
3. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon. Annu Rev Immunol 1997;15:749-95
4. +CD45RB low-density cells from untreated mice prevent acute allograft rejection. J Immunol 1999;16310:5353-7
5. Fecteau S, Basadonna GP, Freitas A, Ariyan C, Sayegh MH, Rothstein DM. CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat Immunol 2001;2:58-63
6. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-42
7. Hathcock KS, Laszlo G, Dickler HB, Sharrow SO, Johnson P, Trowbridge IS, Hodes RJ. Expression of variable exon A-, B-, and C-specific CD45 determinants on peripheral and thymic T cell population. J Immunol 1992;148:19-28
8. Hermiston ML, Xu Z, Weiss A. CD45: A critical regulator of signaling thresholds in immune cells. Annu Rev Immunol 2003;21:107-37
9. Kenyon NS, Chatzipetrou M, Masetti M, Ranuncoli A, Oliveira M, Wagner JL, Kirk AD, Harlan DM, Burkly LC, Ricordi C. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci USA 1999;96:8132-7
10. Kenyon NS, Fernandez LA, Lehmann R, Masetti M, Ranuncoli A, Chatzipetrou M, Iaria G, Han D, Wagner JL, Ruiz P, Berho M, Inverardi L, Alejandro R, Mintz DH, Kirk AD, Harlan DM, Burkly LC, Ricordi C. Long-term survival and function of intra-hepatic islet allografts in baboons treated with humanized anti-CD154. Diabetes 1999;48:1473-81
11. Kim A, Noh YW, Kim KD, Jang YS, Choe YK, Lim JS. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination. Exp Mol Med 2004;36:428-43
12. Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong Y, Gray GS, Hong X, Thomas D, Fechner JH Jr, Knechtle SJ. CTLA-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997;94:8789-94
13. Kirk AD, Burkly LC, Batty DS, Baumgartner RE, Berning JD, Buchanan K, Fechner JH Jr, Germond RL, Kampen RL, Patterson NB, Swanson SJ, Tadaki DK, TenHoor CN, White L, Knechtle SJ, Harlan DM. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in non-human primates. Nat Med 1999;5:686-93
14. Lazarovits AI, Poppema S, Zhang Z, Khandaker M, Le Feuvre CE, Singhal SK, Garcia BM, Ogasa N, Jevnikar AM, White MH, Singh G, Stiller CR, Zhong RZ. Prevention and reversal allograft rejection by antibody against CD45RB. Nature 1996;380:717-20
15. Molano RD, Pileggi A, Berney T, Poggioli R, Zahr E, Oliver R, Ricordi C, Rothstein DM, Basadonna GP, Inverardi L. Prolonged islet allograft survival in diabetic NOD mice by targeting CD45RB and CD154. Diabetes 2003;52:957-64
16. Neujahr DC, Chen C, Huang X, Markmann JF, Cobbold S, Waldmann H, Sayegh MH, Hancock WW, Turka LA. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol 2006;176:4632-9
17. Rothstein DM, Livak MF, Kishimoto K, Ariyan C, Qian HY, Fecteau S, Sho M, Deng S, Zheng XX, Sayegh MH, Basadonna GP. Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models. J Immunol 2001;166:322-9
18. Sayegh MH, Akalin E, Hancock WW, Russell ME, Carpenter CB, Linsley PS, Turka LA. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995;181:1869-74
19. + effector and memory T cell generation. Nat Immunol 2003;4:835-42
20. Shen S, Ding Y, Tadokoro CE, Olivares-Villagomez D, Camps-Ramirez M, Curotto de Lafaille MA, Lafaille JJ. Control of homeostatic proliferation by regulatory T cells. J Clin Invest 2005;115:3517-26
21. + cells, and the alloreactive T cell clone size. J Immunol 2002;169:3744-51
22. Sung Hee Yoon, Hyun Il Cho, Tai Gyu Kim. Activation of B cells using Schneider 2 cells expressing CD40 ligand for the enhancement of antigen presentation in vitro. Exp Mol Med 2005;37:567-74
23. Sutherland RM, McKenzie BS, Zhan Y, Corbett AJ, Fox-Marsh A, Georgiou HM, Harrison LC, Lew AM. Anti-CD45RB antibody deters xenograft rejection by modulating T cell priming and homing. Int Immunol 2002;14:953-62
24. Tilney NL, Whitley WD, Diamond JR, Kupiec-Weglinski JW, Adams DH. Chronic rejection - an undefined conundrum. Transplantation 1991;52:389-98
25. + T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999;104:1715-22
26. Trowbridge IS, Thomas ML. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 1994;12:85-116
27. Williams MA, Trambley J, Ha J, Adams AB, Durham MM, Rees P, Cowan SR, Pearson TC, Larsen CP. Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J Immunol 2000;165:6849-57
28. Wu Z, Bensinger SJ, Zhang J, Chen C, Yuan X, Huang X, Markmann JF, Kassaee A, Rosengard BR, Hancock WW, Sayegh MH, Turka LA. Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 2004;10:87-92
29. + T cells operates via CD4-dependent and CD4-independent mechanism and is CD154 blockade sensitive. J Immunol 2003;170:3024-8